Software Healthcare Sector

Genetic Signatures

Market Cap: AU$18.2m

Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.

Ayr Wellness

Market Cap: CA$18.1m

Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods in United States.

IDT Australia

Market Cap: AU$18.0m

Engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States.

Pacific Health Care Organization

Market Cap: US$12.8m

Operates as a workers’ compensation cost containment company in the United States.

FLUENT

Market Cap: US$12.8m

Through its subsidiaries, cultivates, manufactures, processes, distributes, and sells medical cannabis products for medical and adult-use in the United States.

Anebulo Pharmaceuticals

Market Cap: US$12.8m

A clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States.

Aspira Women's Health

Market Cap: US$12.6m

Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States.

Healthcare Triangle

Market Cap: US$12.6m

A healthcare information technology company, focuses on advancing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry.

TrivarX

Market Cap: AU$17.3m

A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.

Pharma-Bio Serv

Market Cap: US$12.4m

Operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.

Daré Bioscience

Market Cap: US$12.3m

Develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States.

Kiora Pharmaceuticals

Market Cap: US$12.2m

A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.

PDS Biotechnology

Market Cap: US$12.1m

A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States.

PreAxia Health Care Payment Systems

Market Cap: US$12.1m

Engages in the development, distribution, marketing, and sale of health care payment processing services and personal financial management applications, websites, and products.

Rize Oncology

Market Cap: US$12.1m

A biopharmaceutical company, focuses on the development of precision gene editing for human therapeutics applications.

ImExHS

Market Cap: AU$16.9m

Offers cloud-based medical imaging solutions in Australia and internationally.

Picard Medical

Market Cap: US$12.0m

Engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products.

Instinct Bio Technical Company Holdings

Market Cap: US$11.9m

Instinct Bio Technical Company Holdings Inc.

Moleculin Biotech

Market Cap: US$11.9m

A late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses.

MedX Health

Market Cap: CA$16.4m

Develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally.

Izotropic

Market Cap: CA$16.4m

A research and development company, develops diagnostic products for detecting breast cancers.

CytoMed Therapeutics

Market Cap: US$11.8m

A clinical stage biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore.

Senti Biosciences Holdings

Market Cap: US$11.8m

A clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases.

IN8bio

Market Cap: US$11.6m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases.

VVT Med

Market Cap: CA$16.0m

Develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins.

Frequency Exchange

Market Cap: CA$15.9m

Focuses on the development and commercialization of a wearable frequency delivery system that provides programs for health, wellness, and performance enhancement.

Solvonis Therapeutics

Market Cap: UK£8.3m

A clinical-stage biopharmaceutical company, develops medicines for addiction, psychiatry, and neurology disorders.

DiagnosTear Technologies

Market Cap: CA$15.6m

An ophthalmic company, develops and commercializes disruptive diagnostic solutions for eye diseases.

Neurotech International

Market Cap: AU$15.8m

A clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia.

Genvor

Market Cap: US$11.3m

Develops plant-based defense technology designed to help farmers achieve global food security.

Zeo ScientifiX

Market Cap: US$11.3m

A clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines.

Numinus Wellness

Market Cap: US$11.3m

Provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States.

Regentis Biomaterials

Market Cap: US$11.2m

A regenerative medicine company, develops and commercializes tissue repair solutions in the United States.

Brainstorm Cell Therapeutics

Market Cap: US$11.0m

A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.

House of Jane

Market Cap: US$11.0m

Provides lifestyle therapy products.

UMC

Market Cap: US$11.0m

Provides medical insurance claims coding and processing, electronic medical records storage, chargemaster review, pricing comparison, and accounts receivable management services to healthcare providers.